Swiss Cancer Institute

Skipping Hormone Therapy in Low-Risk Early Breast Cancer

Collaborator, Phase 2, Recruiting, 2026, 700 people, 22 Jun 2026, clinicaltrials.gov

NCT06835049

Phase 2, Recruiting, 2025, 24 people, 19 Feb 2025, clinicaltrials.gov

NCT06284122

Collaborator, Phase 3, Active, not recruiting, 2024, 790 people, 28 Feb 2024, clinicaltrials.gov

NCT04630730

Phase 2, Active, not recruiting, 2022, 46 people, 16 Nov 2020, clinicaltrials.gov

NCT03886649

Phase 1, Terminated, 2019, 7 people, 22 Mar 2019, clinicaltrials.gov

NCT03708003

Phase 2, Terminated, 2019, 30 people, 16 Oct 2018, clinicaltrials.gov

NCT03520985

Phase 2, Terminated, 2018, 34 people, 11 May 2018, clinicaltrials.gov

NCT02964689

Phase 1, Completed, 2017, 18 people, 16 Nov 2016, clinicaltrials.gov

NCT02950051

Collaborator, Phase 3, Completed, 2016, 926 people, 31 Oct 2016, clinicaltrials.gov

NCT02945813

Phase 2, Terminated, 2017, 112 people, 26 Oct 2016, clinicaltrials.gov

NCT02877550

Phase 1, Completed, 2017, 25 people, 24 Aug 2016, clinicaltrials.gov

NCT02833766

Phase 2, Terminated, 2016, 48 people, 14 Jul 2016, clinicaltrials.gov

NCT02640534

Phase 2, Terminated, 2016, 169 people, 29 Dec 2015, clinicaltrials.gov

NCT02467582

Phase 3, Terminated, 2016, 1,040 people, 10 Jun 2015, clinicaltrials.gov

NCT02451111

Phase 2, Terminated, 2015, 190 people, 21 May 2015, clinicaltrials.gov

NCT02356458

Phase 1/2, Terminated, 2015, 58 people, 5 Feb 2015, clinicaltrials.gov

NCT02188537

Phase 2, Completed, 2014, 34 people, 11 Jul 2014, clinicaltrials.gov

NCT02051218

Phase 3, Active, not recruiting, 2014, 1,380 people, 31 Jan 2014, clinicaltrials.gov

NCT01835236

Phase 2, Completed, 2013, 208 people, 18 Apr 2013, clinicaltrials.gov

NCT01593241

Phase 2, Terminated, 2012, 120 people, 8 May 2012, clinicaltrials.gov